Cargando…

Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy

PURPOSE: To evaluate the feasibility of the use of real-time magnetic resonance imaging (MRI)-transrectal ultrasound (TRUS) fusion guided high-dose-rate brachytherapy (HDR-BT) +/– external beam radiation therapy (EBRT) in patients with histologically-proven local relapse after radical prostatectomy....

Descripción completa

Detalles Bibliográficos
Autores principales: Buchser, David, Gomez-Iturriaga, Alfonso, Melcon, J. Ignacio Rodriguez, Casquero, Francisco, Llarena, Roberto, Cacicedo, Jon, Bilbao, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241376/
https://www.ncbi.nlm.nih.gov/pubmed/28115952
http://dx.doi.org/10.5114/jcb.2016.64441
_version_ 1782496176470228992
author Buchser, David
Gomez-Iturriaga, Alfonso
Melcon, J. Ignacio Rodriguez
Casquero, Francisco
Llarena, Roberto
Cacicedo, Jon
Bilbao, Pedro
author_facet Buchser, David
Gomez-Iturriaga, Alfonso
Melcon, J. Ignacio Rodriguez
Casquero, Francisco
Llarena, Roberto
Cacicedo, Jon
Bilbao, Pedro
author_sort Buchser, David
collection PubMed
description PURPOSE: To evaluate the feasibility of the use of real-time magnetic resonance imaging (MRI)-transrectal ultrasound (TRUS) fusion guided high-dose-rate brachytherapy (HDR-BT) +/– external beam radiation therapy (EBRT) in patients with histologically-proven local relapse after radical prostatectomy. MATERIAL AND METHODS: We retrospectively reviewed 13 patients treated with real-time MRI-TRUS fusion HDR-BT for a local relapse of prostate cancer after radical surgery. All patients underwent multiparametric magnetic resonance imaging (mpMRI) to confirm the presence of macroscopic lesions in prostate bed, and choline positron emission tomography/computed tomography (PET/CT) to rule out nodal or distant metastases. Local failure was confirmed by transrectal biopsy. Patients without previous EBRT received 1 fraction of 15 Gy with HDR-BT plus hypofractionated EBRT (37.5 Gy in 15 fractions). Two patients received 2 fractions of 12 Gy with HDR-BT without EBRT. Follow-up visits were at 1, 3, 6 months, and every 6 months thereafter. RESULTS: After a median follow-up of 7 months, all patients showed an appropriate biochemical response. Median prostate-specific antigen (PSA) levels before treatment, 1 month, and 6 months after HDR-BT were 2.62 ng/ml (range: 1.55-9.61), 0.97 ng/ml (range: 0.12-3.14), 0.23 ng/ml (range: 0.1-0.74), respectively. Five patients (42%) experienced acute grade 1 GU toxicity and 1 patient (8%) suffered from grade 2 GU toxicity. Regarding gastrointestinal (GI) toxicity, 5 patients referred grade 1 acute toxicity and 1 grade 2 (proctitis). No late toxicity has been observed so far. CONCLUSIONS: MRI-TRUS fusion guided salvage HDR-BT +/– EBRT is a feasible procedure for patients with local macroscopic relapse in tumor bed after radical prostatectomy. Exquisite selection of patients through mpMRI and choline PET/CT is crucial to avoid overtreatment. A larger number of patients and longer follow-up are required in order to draw more solid conclusions regarding the effectiveness of this strategy.
format Online
Article
Text
id pubmed-5241376
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-52413762017-01-23 Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy Buchser, David Gomez-Iturriaga, Alfonso Melcon, J. Ignacio Rodriguez Casquero, Francisco Llarena, Roberto Cacicedo, Jon Bilbao, Pedro J Contemp Brachytherapy Original Paper PURPOSE: To evaluate the feasibility of the use of real-time magnetic resonance imaging (MRI)-transrectal ultrasound (TRUS) fusion guided high-dose-rate brachytherapy (HDR-BT) +/– external beam radiation therapy (EBRT) in patients with histologically-proven local relapse after radical prostatectomy. MATERIAL AND METHODS: We retrospectively reviewed 13 patients treated with real-time MRI-TRUS fusion HDR-BT for a local relapse of prostate cancer after radical surgery. All patients underwent multiparametric magnetic resonance imaging (mpMRI) to confirm the presence of macroscopic lesions in prostate bed, and choline positron emission tomography/computed tomography (PET/CT) to rule out nodal or distant metastases. Local failure was confirmed by transrectal biopsy. Patients without previous EBRT received 1 fraction of 15 Gy with HDR-BT plus hypofractionated EBRT (37.5 Gy in 15 fractions). Two patients received 2 fractions of 12 Gy with HDR-BT without EBRT. Follow-up visits were at 1, 3, 6 months, and every 6 months thereafter. RESULTS: After a median follow-up of 7 months, all patients showed an appropriate biochemical response. Median prostate-specific antigen (PSA) levels before treatment, 1 month, and 6 months after HDR-BT were 2.62 ng/ml (range: 1.55-9.61), 0.97 ng/ml (range: 0.12-3.14), 0.23 ng/ml (range: 0.1-0.74), respectively. Five patients (42%) experienced acute grade 1 GU toxicity and 1 patient (8%) suffered from grade 2 GU toxicity. Regarding gastrointestinal (GI) toxicity, 5 patients referred grade 1 acute toxicity and 1 grade 2 (proctitis). No late toxicity has been observed so far. CONCLUSIONS: MRI-TRUS fusion guided salvage HDR-BT +/– EBRT is a feasible procedure for patients with local macroscopic relapse in tumor bed after radical prostatectomy. Exquisite selection of patients through mpMRI and choline PET/CT is crucial to avoid overtreatment. A larger number of patients and longer follow-up are required in order to draw more solid conclusions regarding the effectiveness of this strategy. Termedia Publishing House 2016-12-06 2016-12 /pmc/articles/PMC5241376/ /pubmed/28115952 http://dx.doi.org/10.5114/jcb.2016.64441 Text en Copyright: © 2016 Termedia Sp. z o. o. http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Original Paper
Buchser, David
Gomez-Iturriaga, Alfonso
Melcon, J. Ignacio Rodriguez
Casquero, Francisco
Llarena, Roberto
Cacicedo, Jon
Bilbao, Pedro
Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy
title Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy
title_full Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy
title_fullStr Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy
title_full_unstemmed Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy
title_short Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy
title_sort salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241376/
https://www.ncbi.nlm.nih.gov/pubmed/28115952
http://dx.doi.org/10.5114/jcb.2016.64441
work_keys_str_mv AT buchserdavid salvagehighdoseratebrachytherapyforhistologicallyconfirmedmacroscopiclocalrelapsedprostatecancerafterradicalprostatectomy
AT gomeziturriagaalfonso salvagehighdoseratebrachytherapyforhistologicallyconfirmedmacroscopiclocalrelapsedprostatecancerafterradicalprostatectomy
AT melconjignaciorodriguez salvagehighdoseratebrachytherapyforhistologicallyconfirmedmacroscopiclocalrelapsedprostatecancerafterradicalprostatectomy
AT casquerofrancisco salvagehighdoseratebrachytherapyforhistologicallyconfirmedmacroscopiclocalrelapsedprostatecancerafterradicalprostatectomy
AT llarenaroberto salvagehighdoseratebrachytherapyforhistologicallyconfirmedmacroscopiclocalrelapsedprostatecancerafterradicalprostatectomy
AT cacicedojon salvagehighdoseratebrachytherapyforhistologicallyconfirmedmacroscopiclocalrelapsedprostatecancerafterradicalprostatectomy
AT bilbaopedro salvagehighdoseratebrachytherapyforhistologicallyconfirmedmacroscopiclocalrelapsedprostatecancerafterradicalprostatectomy